This study was designed to investigate the influence of anaesthesia induced and maintained with propofol on the haemodynamic effects and the dose requirements of SNP during the course of induced hypotension.
Induced hypotension using sodium nitroprusside (SNP) is an accepted intra-operative technique for reducing blood loss and improving surgical conditions. Despite its attractive pharmacodynamics, the use of high doses of SNP infusions may be associated with increased potential for cyanide toxicity! In situations where high doses or prolonged infusions of SNP are anticipated, an anaesthetic technique that reduces the dose requirements for SNP would be desirable.
Propofol (2, 6 di-isopropyl phenol) is a short-acting intravenous anaesthetic with a pharmacokinetic profile allowing its use for induction as well as for continuous infusion anaesthesia. 2 Propofol anaesthesia had been frequently reported to induce significant reduction in systemic vascular resistance and arterial blood pressure without compensatory increase in the heart rate. J5 These haemodynamic features of propofol may be of particular value during the course of induced hypotension.
METHODS
After institutional approval, 24 adult patients, aged 20-40 years and of physical status ASA I undergoing elective middle ear surgery, gave informed consent to participate in the present study. Preoperative assessment included complete blood picture, serum electrolytes, liver function tests, serum creatinine and I2-lead ECG recording. Patients with a history of cardiovascular, renal, central nervous system, hepatic or lung dysfunction or those receiving any medications known to interfere with the autonomic control of the cardiovascular functions were excluded. All patients were premedicated with diazepam 0.2 mg.kg -I given orally 90 minutes before surgery.
On arrival at the operating room, a 20-gauge radial artery Teflon cannula and two IS-gauge peripheral venous cannulae were placed under local analgesia. A slow IV infusion of 5070 dextrose in lactated Ringer's solution was started to replace intra-operative insensible loss. An IS-gauge drum cartridge catheter (Abbott Laboratories) was advanced centrally from an antecubital vein. Lead II ECG, direct arterial blood pressure and central venous pressure (CVP) were displayed continuously on an oscilloscope using a Helliga Servomed monitor (Germany). Cardiac output (CO) was monitored non-invasiveiy using a transthoracic electrical bioimpedance cardiograph (NCCOM 3, BoMed, Ohio). A control baseline value of the heart rate (HR), mean arterial blood pressure (MAP), CVP and CO were recorded before induction. Stroke index (SI), cardiac index (Cl) and systemic vascular resistance index (SVRI) were derived by standard formulae.
At the time of induction patients were randomly allocated to one of two groups (n = 12 each), according to the type of induction agent and the maintenance technique. Patient allocation into one of the two study groups was carried out according to randomization tables created by PMDP (1990) statistical package (University of California Press). Anaesthesia was induced with 150 Ilg.kg -I morphine followed by either thiopentone 4 mg.kg -I(group 1) or propofol 2.5 Ilg.kg -I (group 2). Endotracheal intubation was facilitated by the use of 0.5 mg.kg I d-tubocurarine and ventilation was controlled to maintain normocapnia. Anaesthesia was maintained with 70070 N20 in oxygen supplemented with either 0.6070 endtidal halothane concentration (group 1) or a continuous infusion of propofol, at a rate of 108 Ilg.kg -Imin -I (group 2). Halothane concentration and propofol infusion rate were not altered during the maintenance. Signs of light anaesthesia such as sweating or slight patient movement were controlled with bolus doses of thiopentone 50 mg (group 1) or propofol 20 mg (group 2). End-tidal halothane concentration and O 2 saturation were monitored using a respiratory gas monitor (Ohmeda, Englewood BOC, USA). Normocapnia was ensured by arterial blood gas tensions measured every thirty minutes during the course of anaesthesia.
A second reading of all haemodynamic variables was recorded 15 minutes after the beginning of surgery and just before institution of induced hypotension. SNP infusion 0.01 070 was started at a rate of 1 Ilg.kg -I. min -I. This was gradually increased until the mean arterial blood pressure was reduced to 60-65 mmHg or a dose of 10 Ilg.kg -I of SNP has been given. Patients exceeding this dose level were excluded from the study and additional therapy was instituted at the direction of the attending anaesthesiologist. For each patient, the mean SNP requirement was the total dose divided by the duration of induced hypotension in minutes.
During the course of induced hypotension, a reflex persistent increase in HR exceeding 100 beats.min -I , was treated with 0.5 mg increments of propranolol. Haemodynamic variables were recorded during the steady state hypotension and for 15 minutes following SNP withdrawal. At the conclusion of surgery, residual neuromuscular blockade was antagonised with neostigmine and atropine. The trachea was extubated and patients were transferred to the recovery room.
Statistical comparisons of haemodynamic changes within each group were performed using repeated measures analysis of variance (ANOVA). The differences between halothane and propofol anaesthesia were tested for statistical significance using unpaired Student's t-test. For all statistical comparisons a P value < 0.05 indicated significant difference.
RESULTS
All results are expressed as mean ± so. All patients completed the study and there were no significant differences in the demographic and pre-induction haemodynamic values between the two groups ( Table  1, 2) The mean duration of induced hypotension was 63 ± 8 and 58 ± 23 minutes in group 1 and 2, respectively. A mean arterial blood pressure of 60-65 mmHg was achieved with SNP infusions in all patients and operative conditions were reported to be satisfactory by the surgeon. In contrast with halothane, propofol produced a significant reduction in MAP (17070) before SNP infusion (P<O.01). One patient in the propofol group did not require any SNP infusion and maintained an MAP of 60-68 mmHg during the course of anaesthesia. Withdrawal of SNP was not associated with rebound hypertension in any of the patients studied. Mean blood pressure continued to be significantly reduced (P < 0.05) in the propofol group after SNP withdrawl (Table 2, Figure 1 ). The mean SNP dose requirements were 7.25 ± 1.6 and 2.1 ± 1.4
Ilg.kg -1. min -\ in the halothane and propofoi groups, respectively (P < 0.0001). ... The changes in the SVRI followed the same pattern for MAP. Compared with halothane, propofol produced a significant (P< 0.01) 24070 reduction in SVRI before institution of induced hypotension. At steady state hypotension (MAP of 60-65 mmHg), SVRI was reduced by 35070 and 36070 in the halothane and propofol groups, respectively. The difference was not statistically significant. Following withdrawal of SNP infusions, SVRI returned to the control value in the halothane group and continued to be significantly reduced (P < 0.01) in the propofol group (Table 2, Figure 1 ).
Patients receiving halothane anaesthesia had a significant increase in the heart rate compared with those receiving propofol before SNP infusion (Table 2, Figure 2 ). Sodium nitroprusside infusion resulted in a significant (36070) reflex increase in HR in the halothane group (P<O.OO1). Propranolol 0.5-3 mg (1.2 ± 1 mg) was required in eight out of 12 patients in this group (66070) to maintain the HR less than 100 beat.min ~ I. In contrast, propofol anaesthesia produced insignificant changes in the heart rate all through the course of anaesthesia and induced hypotension (Table 2, Figure 2 ). Only two patients (16070) in the propofol group required single dose of 0.5 mg propranolol to control reflex tachycardia during the steady state hypotension.
Stroke index was significantly reduced (P < 0.01) during SNP infusion in the halothane group. However, Cl was not significantly different compared with the awake value. Intraoperative values for SI and Cl were not significantly different from the awake value during propofol anaesthesia. In the two groups studied, a significant reduction in the CVP was only noted during steady state hypotension ( Table 2) .
DISCUSSION
The hypotensive effects of SNP are the result of both the primary direct vasodilator effect on vascular smooth muscles, which tend to lower blood pressure, and the compensatory homeostatic reflexes that act to limit the decrease in blood pressure. 6 The homeostatic response to induced hypotension is thought to be related to reflex sympathetic stimulation mediated by a baroreceptor mechanism that results in the release of endogenous catecholamines and activation of the renin-angiotensin system. 7 This reflex homeostatic response has two main components, namely, an increase in the heart rate and a reflex increase in systemic vascular resistance. 8 Under conditions where a high degree of central vasomotor tone is present, e.g. the young age group included in the present study, this reflex homeostatic response has been reported to counteract the direct vasodilator effects of SNP resulting in the need for greater dose requirements:
In the present study, the two components of the reflex homeostatic response to SNP induced hypotension were altered by the concomitant administration of propofol anaesthesia. Propofol attenuated significantly the reflex tachycardia during SNP hypotension. This beneficial effect of propofol is related to its influence on the baroreceptor homeostatic mechanisms. Cullen and his colleagues' demonstrated that propofol infusions during N 2 0 oxygen anaesthesia produced marked resetting of the baroreflex set point to allow a low arterial blood pressure without compensatory increase in the HR. A direct effect of propofol on the sinus node has been also been implicated. 9 The induction and maintenance doses of propofol used in the present study produced about 24070 reduction in the SVRI and 17070 reduction in MAP prior to SNP administration. Several studies documented the hypotensive effects of propofol anaesthesia and attributed this to a reduction in the systemic vascular resistance. J5 PropofollN 2 0 anaesthesia has also been reported to attentuate the baroreflex mediated arteriolar vasoconstriction. 3 . 8 A direct vasodilator effect for propofol may contribute to its hypotensive potential. 3 The combined effects of propofol on the baroreceptor homeostatic reflexes and on the systemic vascular resistance account for the marked reduction in SNP dose requirements during the course of propofol anaesthesia. The use of lower doses of SNP during propofol anaesthesia may minimise or prevent the risk of cyanide toxicity. However, in most of the cases it is not the hypotensive agent that influences the outcome, but rather the actual level of blood pressure and how well it is maintained. With non-neurosurgical indications, only a mild to moderate degree of hypotension is required, and the mean arterial blood pressure should not be reduced to less than 50-60mmHg. Below this level the risks of neurological damage outweigh the benefits of reduced bleeding or clear operative field!O In the present study we used moderate degree of hypotensive anaesthesia with the MAP always maintained around 60-65 mmHg. This level of MAP produced satisfactory operative conditions and we did not encounter any complications related to the use of hypotensive technique in either group.
In contrast to propofol, halothane anaesthesia, in the concentration used in the present study, was associated with significant reflex tachycardia in response to SNP induced hypotension. Similar findings have been reported by others.Jl12 Although halothane anaesthesia has been reported to depress baroreceptor functions 13 the addition of 70070 N20 to a background halothane anaesthetic results in less attenuation of baroreceptor reflex mediated cardiac slowing!4
The absence of rebound hypertension after SNP withdrawal in the present study could be related to the concomitant administration of propranolol in the halothane group. Both intravenous" and prophylactic oral'6 propranolol have been reported to reduce circulating catecholamines, inhibit renin release and prevent rebound hypertension after SNP withdrawal. In the propofol group however, the absence of rebound hypertension was related to the continued reduction of SVRI which was present after SNP withdrawal.
The significant difference in SNP requirements between propofol and halothane groups could be related to the insignificant effects of halothane on the SVRI. Prys-Roberts et all' confirmed that the hypotensive action of halothane is mainly due to a reduction in the cardiac output without any significant effect on the systemic vascular resistance. The myocardial depressant effects of halothane may add to the risks associated with hypotensive anaesthesia. This is especially the case when it is used in high concentrations as the sole hypotensive agent 17. In the present study we used moderate concentration of halothane (0.6070 end-tidal) as the background anaesthetic during SNP induced hypotension. In this concentration halothane produced a significant reduction in the SI; however, the Cl was maintained by the reflex increase in the heart rate. In contrast to halothane, the administration of isoflurane during controlled ventilation with normal P aC02 does not greatly reduce the cardiac output and is associated with a dose-related reduction in systemic vascular resistance which may augment the hypotensive effects of SNP!' Despite the apparent advantages of isoflurane over halothane during hypotensive techniques we have used the latter because it is still the most popular inhalational anaesthetic in our area. The depth of anaesthesia may affect the degree of vagal tone and thus the heart rate response to induced hypotension. The comparability of the depth of anaesthesia achieved by the two techniques utilised in the present study was considered. Prys-Roberts'9 justified the comparison of equipotent doses of intravenous and inhalational anaesthetics on the basis that the efficacy of both agents measured by the minimum infusion rate (MlR) or minimal alveolar concentration (MAC) is dependent on the same endpoint which is the minimum dose required to prevent movement in response to initial surgical stimulation in 50070 of patients. In the present study anaesthesia was induced in the two groups with equal doses of morphine and equipotent doses of thiopentone and propofol. 20 The steady state infusion rate of propofol was equivalent to double the reported value for MlR during 70% N20 anaesthesia." The end-tidal halothane concentration used for patients in group 1 was also equivalent to double the MAC value in 70070 N2o. 22 It is therefore valid to regard any difference demonstrated in the haemodynamic response to SNP as primarily reflecting the effects of halothane in group 1 and of propofol in group 2.
In conclusion, we have demonstrated that propofol anaesthesia reduced significantly the dose of SNP required to bring about a given degree of induced hypotension. Propofol also attenuated the reflex mediated tachycardia and prevented rebound hypertension after SNP withdrawal. Propofol and SNP appears to be a rational drug combination, bringing about additive desirable effects with less deleterious reflex response during the course of induced hypotension.
